Concourse Financial Group Securities, Inc. Tc Bio Pharm (Holdings) PLC Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$0.26 - $2959.0 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.34 - $1.67 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$0.9 - $2.12 $0 - $0
0 New
0 $0

About TC BioPharm (Holdings) plc

TCBP Quotes by TradingView
  • Ticker TCBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,747,700
  • Market Cap $28.2M
  • Description
  • TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19...
More about TCBP
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email